Grace Therapeutics (GRCE) Revenue (2020 - 2021)
Grace Therapeutics (GRCE) posted Revenue of $115000.0 for Q1 2021, up 41.98% sequentially from $81000.0 in Q4 2020.
Grace Therapeutics (GRCE) Revenue (2020 - 2021) Analysis & Trends
Grace Therapeutics has reported Revenue for 2 years, with the latest figure at $115000.0 in Q1 2021.
- Quarterly Revenue changed N/A year-over-year to $115000.0 in Q1 2021, while the trailing twelve-month figure through Mar 2022 was $196000.0 (changed N/A YoY) and the FY2021 annual result came in at $196000.0, changed N/A from the prior year.
- Revenue rose to $115000.0 in Q1 2021 per GRCE's latest filing, from $81000.0 in the prior quarter.
- Over five years, Revenue peaked at $115000.0 in Q1 2021 and troughed at $81000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Grace Therapeutics | 37.04 Mn | 37.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 115,000.00 |
| Dec 31, 2020 | 81,000.00 |